When I first started working as a dietitian, I frequently requested serum B12 levels and adjusted supplementation based on the results. But one thing I never stopped to question was this:
How reliable is serum B12 as a marker of true B12 status?
As it turns out—the answer is more complicated than I expected.
To write this post, I consulted several papers:
- Green, Ralph. “Vitamin B12 deficiency from the perspective of a practicing hematologist.” Blood, The Journal of the American Society of Hematology 129.19 (2017): 2603-2611.
- Wu, Henry HL, and Angela Yee-Moon Wang. “Vitamin B12 and chronic kidney disease.” Vitamins and hormones 119 (2022): 325-353.
- Araji, Ghada, et al. “Vitamin B12 deficiency in dialysis patients: risk factors, diagnosis, complications, and treatment: a comprehensive review.” World Journal of Nephrology 13.4 (2024): 100268.
Let’s dig in.
Are Serum Vitamin B12 Levels Good Indicators of B12 Status?
No. Serum B12 alone is considered a poor marker for reliably detecting B12 deficiency.
Low serum B12 does not necessarily mean deficiency. Likewise, normal levels do not guarantee adequacy.
Why Can Someone Have Normal B12 Levels but Still Be Deficient?
Vitamin B12 circulates in the blood bound to two proteins:
- Haptocorrin (70–90%) → inactive form, not available for cellular use
- Transcobalamin (10–30%) → active form, delivers B12 to cells
Standard serum B12 tests measure total B12, not just the active fraction.
This means a patient could have:
- Normal total B12
- But low active (transcobalamin-bound) B12
And still be functionally deficient.
Why Do Some People With Low Serum B12 Not Have True Deficiency?
Studies suggest that up to 50% of people with low serum B12 levels have normal methylmalonic acid (MMA) and homocysteine levels, and show no hematologic or neurologic response to B12 supplementation.
This suggests many low serum B12 results may be false positives, rather than true deficiency.
When Does Serum B12 Produce False Negative or False Positive Results?
False negatives (normal B12 despite deficiency)
These can occur in:
- Nitrous oxide exposure
- Functional transcobalamin deficiency
- Inborn errors of cobalamin metabolism
False positives (low B12 without deficiency)
These can occur in:
- Vegetarians
- High vitamin C intake
- Benign inherited haptocorrin deficiency
- Folate deficiency
What About Serum B12 Testing in CKD and Dialysis Patients?
The same limitations exist—but may be even more pronounced.
In CKD and dialysis patients, serum B12 may appear normal or elevated due to accumulation of inactive B12 analogues, which are not biologically functional.
This means:
Serum B12 may overestimate true B12 status in dialysis patients.
Evidence Example: Normal B12 but Functional Deficiency
In one study of dialysis patients with macrocytic anemia:
- Serum B12 levels were normal
- MMA levels were elevated
- After IV B12 supplementation, MMA decreased
However:
- Hemoglobin did not improve
- Reticulocyte count did not improve
- MCV did not improve
This highlights the complexity of interpreting B12 markers in CKD.
If Serum B12 Isn’t Reliable, What Other Tests Can Help?
No single test is perfect. Instead, diagnosis requires interpretation of multiple markers alongside clinical context.
Alternate Tests and Their Limitations
| Name | Abbreviation | Result if B12 deficiency | Comments | Accurate for renal patients |
| Serum HoloTranscobalamin | Serum holoTC | Low | Measures the active form of Vitamin B12 | Appeared accurate in one study, but the study design has been questioned. Considered unknown for reliability. |
| Methylmalonic Acid | MMA | High | While a sensitive marker of B12 deficiency, shouldn’t be used in isolation to determine B12 status. History of GI surgery & small bowel bacterial overgrowth can also cause MMA elevations. | Not considered accurate in people with impaired renal function as CKD (especially when on dialysis) tends to be associated with increased MMA levels |
| Homocysteine | Hcy | High | A sensitive marker of B12 deficiency. Best measured in plasma vs serum. Hcy can also be elevated with folate or pyridoxine deficiencies or hypothyroidism. | Not considered accurate in people with impaired renal function as CKD tends to be associated with increases in Hcy levels. |
Do Vitamin B12 Levels Affect Outcomes in CKD?
The short answer: We don’t really know.
Vitamin B12 has been studied in relation to:
- Mortality
- Cardiovascular risk
- Neuropathy
- Anemia and ESA requirements
Results are inconsistent.
Mortality and Cardiovascular Outcomes
One large study of 20,000 hemodialysis patients found:
- B12 levels above 550 pg/mL were associated with increased mortality risk
However, other studies examining homocysteine and outcomes have reported:
- Lower mortality with higher levels
- Higher mortality with lower levels
- Or no association
The HOST trial (2056 patients) found that although B12 supplementation reduced homocysteine levels, this did not translate into cardiovascular or mortality benefit.
Neuropathy Outcomes
Results are also mixed.
One study found improvement in neuropathic pain with B12 injections.
Another found B12 supplementation was associated with:
- Increased cyanide levels
- Reduced clearance
- Worse uremic neuropathy symptoms
Anemia and ESA Requirements
Studies evaluating whether B12 reduces ESA requirements (such as darbepoetin) have also shown mixed results.
No clear benefit has been consistently demonstrated.
Clinical Takeaways
This is one of those topics where the deeper you dig, the more uncertainty you uncover.
Here’s what we currently know:
- Serum B12 is not a reliable indicator of true B12 status
- Functional markers (MMA, homocysteine, holoTC) may help in the general population
- However, these markers are also limited in CKD
- B12 supplementation has not consistently demonstrated clear clinical benefit in CKD populations
That said, one important unanswered question remains:
Perhaps the lack of benefit reflects our inability to accurately identify true deficiency.
It’s possible that supplementation helps those who are deficient—but provides no benefit, or potential harm, to those who are already sufficient.
This remains an important area for future research.
